Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel preparation method for spirocyclic indole diphenols via Eaton reagent cyclization. Offers cost-effective route for chiral catalyst precursors with high scalability.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Novel two-step route using bis-ketal glucose enables high-purity chiral monomers for reusable polymer-supported asymmetric catalysis applications.
Novel asymmetric synthesis of antitumor pyrano-pyrazole derivatives via chiral phosphine catalysis. Offers high enantioselectivity and scalable routes for API intermediates.
Novel Mn-catalyzed asymmetric oxidation offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN107540616B details a novel 4-step route to chiral pyrazolamines with 94% ee, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical manufacturing.
Patent CN103012498A reveals high-efficiency Ir-catalysts for ketone reduction, offering scalable routes for chiral pharmaceutical intermediates.
Patent CN120965569A reveals double five-membered ring ligands enhancing stereoselectivity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel chiral thioether-phosphine compounds for Pd-catalyzed asymmetric allylic alkylation. Efficient synthesis, high yield, reliable supply chain for pharmaceutical intermediates.
Patent CN115403593A details a novel Ni-catalyzed [3+2] cycloaddition for chiral purine oxazoles, offering high yields and scalable routes for reliable pharmaceutical intermediate suppliers.
Patent CN1468212A introduces a safe, cost-effective asymmetric cyanation method using alkali metal cyanides and chiral titanium catalysts for high-purity pharmaceutical intermediates.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.
Patent CN112142791B reveals high-ee asymmetric fluorination. Enables cost reduction in pharma intermediate manufacturing with scalable supply chain solutions.
Novel asymmetric catalysis method improves yield and purity for Carfilzomib intermediate manufacturing ensuring supply chain stability and cost efficiency.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN111995544B details a novel Pd-catalyzed route offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN104099305A reveals stable CgKR1 mutants for Clopidogrel intermediates. Enhances purity and supply chain reliability for global pharmaceutical manufacturing.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.